Performing chorionic villus sampling (CVS) for prenatal diagnosis may lead to an increased rate of blood vessel malformations called hemangiomas in infants, according to a review in the November Journal of Craniofacial Surgery. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals, and institutions in medicine, nursing, allied health, pharmacy and the pharmaceutical industry.
Dr. Lewis B. Holmes of Massachusetts General Hospital for Children, Boston, reviews past research on the possible link between CVS and the development of hemangiomas, limb defects, and certain other malformations. According to Dr. Holmes, the findings suggest—but do not prove—some possible ways in which CVS might lead to “vascular disruption defects or hemangiomas.”
Leave a reply